Safer, Better, Faster, and Stronger: Clinical Microbiology and Infection Prevention, a Great Duo in Action

The partnership between clinical microbiology laboratories (CMLs) and infection prevention programs (IPPs) is crucial for protecting patient and community health. Advances in technology, including rapid molecular diagnostics, next-generation sequencing, and laboratory automation, allow for earlier detection of healthcare-associated infections, multidrug-resistant organisms, and emerging pathogens. Close collaboration among CMLs, IPPs, antimicrobial stewardship teams, and infectious disease specialists ensures the appropriate adoption of tests, diagnostic stewardship, and adherence to evidence-based guidelines. Despite challenges like cost constraints, staffing shortages, and the shift toward culture-independent testing, adaptive CML-IPP partnerships remain essential for delivering faster, safer, and more effective health care.